Books and Monographs
1 Hallucinogenic and Poisonous Mushroom Field Guide. [more] 2 ![]()
Flesh of the Gods : The Ritual Use of Hallucinogens. Furst, Peter T. ; (editor/s)
New York : Praeger Publishers, 1972.ADAI BOOK Call No: GN 472.4 F41 1972
[more] 3 Hallucinogens and Culture. (Chandler & Sharp Series in Cross-Cultural Themes) Furst, Peter T.
San Francisco: Chandler & Sharp Publishers, Inc., 1976.ADAI BOOK Call No: HV 5822 H25 F87 1976
[more] 4 Hallucinogenic Drug Research: Impact on Science and Society; Proceedings of the First Annual Symposium of the Student Association for the Study of Hallucinogens. Gamage, James R. ; Zerkin, Edmund L. ; (editor/s)
Beloit, WI: STASH Press, 1970.ADAI BOOK Call No: HV 5822 H25 G23 1970
[more] 5 LSD, Marihuana, Yoga, and Hypnosis. (Modern Applications of Psychology) Barber, Theodore Xenophon
Chicago: Aldine Publishing Company, 1970.ADAI BOOK Call No: BF 209 H34 B23 1970
[more] 6 ![]()
The Peyote Cult / enlarged edition. [more] 7 ![]()
Acid Dreams : The CIA, LSD, and the Sixties Rebellion. Lee, Martin A. ; Shlain, Bruce
New York: Grove Press, Inc., 1985.ADAI BOOK Call No: HV 5822 L9 L44 1985
[more] 8 ![]()
Alternate States of Consciousness : Multiple Perspectives on the Study of Consciousness. [more] 9 ![]()
Hallucinogens ; An Update. (NIDA Research Monograph 146 NIH Pub. no. 94-3872) Lin, Geraline C. ; Glennon, Richard A. ; (editor/s)
Rockville : National Institute on Drug Abuse, 1994.ADAI BOOK Call No: RM 324.8 H25 1994
[more] 10 ![]()
Addiction : From Biology to Drug Policy. [more] 11 ![]()
QuaSAR : Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. (NIDA Research Monograph 22) Barnett, Gene ; Trsic, Milan ; Willette, Robert E. ; (editor/s)
Rockville : National Institute on Drug Abuse, 1978.ADAI BOOK Call No: RM 301.42 Q28 1978
[more] 12 Focus on Hallucinogens. (Drug-Alert series) Shulman, Jeffrey
Frederick, MD : Twenty-First Century Books, 1991.ADAI BOOK Call No: HV 5822 H25 S55 1991
[more] 13 ![]()
Storming Heaven : LSD and the American Dream. [more] 14 Drugs in Relation to the Drug User : Critical Drug Issues. [more] 15 Getting Over Getting High : How to Overcome Dependency on Cocaine, Caffeine, Hallucinogens, Marijuana, Speed, and other Stimulants the Natural and Permanent Way. [more] 16 Hallucinogenic Drugs. (American lecture series no. 825. American lectures in living chemistry) [more] 17 ![]()
Licit and Illicit Drugs: The Consumers Union Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens, and Marijuana - Including Caffeine, Nicotine, and Alcohol. Brecher, Edward M. ; Consumer Reports, editors of.
Boston : Little, Brown, 1972.ADAI BOOK Call No: HV 5825 B72 [REF HAND]
[more] 18 Drugs, Rituals and Altered States of Consciousness. [more] 19 MDMA. Seymour, Richard B. ; Smith, David E. ; Shulgin, Alexander T
San Francisco : Hiaght-Ashbury Publications, 1986.ADAI BOOK Call No: HV 5822 H25 M36 1986
[more] 20 The Natural Mind : A New Way of Looking at Drugs and the Higher Consciousness. [more] 21 On Being Stoned : A Psychological Study of Marijuana Intoxication.
Palo Alto : Science and Behavior Books [1971]ADAI BOOK Call No: BF 209 M3 T37
[more] 22 Psychedelic Reflections. Grinspoon, Lester ; Bakalar, James B. ; (editor/s)
New York, N.Y. : Human Sciences Press, 1983.ADAI BOOK Call No: BF 209 H34 P78 1983
[more] 23 Psychedelics Encyclopedia. Stafford, Peter G. ; Bigwood, Jeremy
Los Angeles : JP Tarcher, 1982.ADAI BOOK Call No: HV 5822 H25 S74 1983 [REF HAND]
[more] 24 Teonanacatl : Hallucinogenic Mushrooms of North America. (Psycho-mycological studies no. 2) Ott, Jonathan ; Bigwood, Jeremy ; (editor/s)
Seattle : Madrona Press, 1978.ADAI BOOK Call No: QK 604.5 I57 1977 [REF HAND]
[more]
Articles, Chapters, and Reprints
25 Interviews with hallucinogenic drug discontinuers. 26 Management of phencyclidine, hallucinogen and marijuana intoxication and withdrawal. Wilkins JN ; Gorelick DA
In: Miller NS (ed.) PRINCIPLES OF ADDICTION MEDICINE. Chevy Chase, MD : American Society of Addiction Medicine, 1994, Sec.XI Chap.8. (Chapter) [Call No: RC 564 M455 1994] [ ]27 Phencyclidine and the hallucinogens. Craig RJ ; Weddington WJ
In: Miller NS (ed.) PRINCIPLES OF ADDICTION MEDICINE. Chevy Chase, MD : American Society of Addiction Medicine, 1994, Sec.II Chap.7. (Chapter) [Call No: RC 564 M455 1994] [ ]28 Hallucinogenic agents: drugs of abuse as neurochemical tools: a symposium. Free Link 29 Lysergamides revisited. Pfaff RC ; Huang X ; Marona-Lewicka D ; Oberlender R ; Nichols DE
NIDA Res Monogr 1994;146:52-73 (Chapter) [Call No: RM 324.8 H25 1994] [ ]Free Link 30 Structure-activity relationships of the classic hallucinogens and their analogs. Free Link 31 Human hallucinogenic drug research: regulatory, clinical, and scientific issues. Free Link 32 Hallucinogens: An Update. Proceedings of a meeting. July 13-14, 1992. Lin GC ; Glennon RA ; (eds.)
NIDA Res Monogr 1994;146:1-301 (Chapter) [Call No: RM 324.8 H25 1994] [ ]Free Link 33 Serotonin receptor involvement in an animal model of the acute effects of hallucinogens. Free Link 34 The stimulus effects of serotonergic hallucinogens in animals. Free Link 35 Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. Free Link 36 Neurochemical evidence that hallucinogenic drugs are 5-HT1c receptor agonists: what next? Free Link 37 Autoradiographic approaches to studying hallucinogens or other drugs. Free Link 38 Hallucinogens acting at 5-HT receptors: toward a mechanistic understanding at atomic resolution. Weinstein H ; Zhang D ; Ballesteros JA
NIDA Res Monogr 1994;146:241-62 (Chapter) [Call No: RM 324.8 H25 1994] [ ]Free Link 39 Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors. Westkaemper RB ; Glennon RA
NIDA Res Monogr 1994;146:263-83 (Chapter) [Call No: RM 324.8 H25 1994] [ ]Free Link 40 Structure and function of serotonin 5-HT2 receptors. Shih JC ; Chen K ; Gallaher TK
NIDA Res Monogr 1994;146:284-97 (Chapter) [Call No: RM 324.8 H25 1994] [ ]Free Link 41 Are hallucinogens psychoheuristic? Free Link 42 Classical hallucinogens: an introductory overview. Free Link 43 Phencyclidine : Experimental studies in animals and long-term developmental effects on humans. Harry GJ ; Howard J
In: Sonderegger TB (ed.) PERINATAL SUBSTANCE ABUSE : RESEARCH FINDINGS AND CLINICAL IMPLICATIONS. Baltimore : The Johns Hopkins University Press, 1992, pp. 254-278 (Chapter) [Call No: RG 627.6 D79 P443 1992] [ ]44 Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. 45 Psychedelic solutions? [LSD, ecstasy, etc.] 46 Discriminative stimulus properties of hallucinogens and related designer drugs. Free Link 47 Discriminative stimulus properties of phencyclidine and other NMDA antagonists. Free Link 48 Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol. 49 LSD and post-hallucinogen perceptual disorder [letter] 50 The never-ending trip [LSD]. Laign J
Adolescence Mag 1994;7(6):19-22 (Journal) [ ]51 Psychedelic and entactogenic drugs in the treatment of depression. 52 Characteristics of men with alcoholic hallucinosis. Tsuang JW ; Irwin MR ; Smith TL ; Schuckit MA
Addiction 1994;89(1):73-8 (Journal) [ PubMed abstract ]53 Treatment of patients for specific drugs of abuse: Hallucinogens. Ungerleider JT ; Pechnick RN
In: Galanter M ; Kleber HD (eds.) THE AMERICAN PSYCHIATRIC PRESS TEXTBOOK OF SUBSTANCE ABUSE TREATMENT. Washington DC : American Psychiatric Press, 1994, pp. 141-147. (Chapter) [Call No: RC 564 A525 1994] [ ]54 Treatment of patients for specific drugs of abuse: Phencyclidine. Daghestani AN ; Schnoll SH
In: Galanter M ; Kleber HD (eds.) THE AMERICAN PSYCHIATRIC PRESS TEXTBOOK OF SUBSTANCE ABUSE TREATMENT. Washington DC : American Psychiatric Press, 1994, pp. 149-154. (Chapter) [Call No: RC 564 A525 1994] [ ]55 Neurochemical substrates underlying the mechanism of action of phencyclidine (PCP). Pechnick RN
In: Korenman SG ; Barchas JD (eds.) BIOLOGICAL BASIS OF SUBSTANCE ABUSE. New York: Oxford University Press, 1993, pp. 285-298 (Chapter) [Call No: RM 316 B56 1993] [ ]56 Animal models for assessing hallucinogenic agents. Glennon RA
In: Boulton AA ; Baker GB ; Wu PH (eds.) ANIMAL MODELS OF DRUG ADDICTION. Totowa, NJ : Humana Press, 1992, pp. 345-382 (Chapter) [Call No: RC 564 A56 1992] [ ]57 Behavioral response to buspirone in cocaine and phencyclidine withdrawal. Giannini AJ ; Loiselle RH ; Graham BH ; Folts DJ
J Subst Abuse Treat 1993;10(6):523-7 (Journal) [ PubMed abstract ]58 Fun, frission & fashion [ecstasy, lsd, amphetamines and nightclubs, raves and parties]. Henderson S
Int J Drug Policy 1993;4(3):122-129 (Journal) [ ]59 Adverse consequences of lysergic acid diethylamide. 60 LSD now: 1973. Chunko JA
J Drug Educ 1973;3(4):339-351 (Journal) [ ]61 Perception, psychedelics, and social change. 62 Three generations of electrophilic affinity ligands for the phencyclidine binding sites. Jacobson AE ; Linders JT ; Rice KC ; Monn JA ; Mattson MV ; George C
NIDA Res Monogr 1992;119:81-5 (Chapter) [Call No: HV 5825 C617 1991] [ ]Free Link 63 Hallucinogens and serotonergic mechanisms. Glennon RA ; Teitler M ; Sanders-Bush E
NIDA Res Monogr 1992;119:131-5 (Chapter) [Call No: HV 5825 C617 1991] [ ]Free Link 64 Mechanisms of toxicity of phenethylamines [letter] 65 The adolescent client using THC and PCP treated in the emergency department. Cervenansky N ; Lanphier S
In: Jack L (ed.) NURSING CARE PLANNING WITH THE ADDICTED CLIENT, Vol. II. Skokie, IL : Midwest Education Association, 1990. pp. 167-190 (Chapter) [Call No: RC 566 N875 v.2] [ ]66 Hallucinogens. Stroup-Menge B
Adolescence Mag 1988;1(5):42 (Journal) [ ]67 Hallucinogens. Ungerleider JT ; Pechnick R
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK. (2nd edition) Baltimore : Williams & Wilkins, 1992. pp.280-289 (Chapter) [Call No: RC 564 S826 1992 [REF HAND]] [ ]68 Phencyclidine. Zukin SR ; Zukin RS
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK. (2nd edition) Baltimore : Williams & Wilkins, 1992. pp.290-302 (Chapter) [Call No: RC 564 S826 1992 [REF HAND]] [ ]69 Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students. 70 Treatment of acute, adverse psychedelic reactions: "I've tripped and I can't get down". Miller PL ; Gay GR ; Ferris KC ; Anderson S
J Psychoactive Drugs 1992;24(3):277-9 (Journal) [ PubMed abstract ]71 The combination of psychedelic and aversive approaches in alcoholism treatment: the affective contra-attribution method. Krupitsky EM ; Grineko AY ; Berkaliev TN ; Paley AI ; Tetrov UN ; Mushkov KA ; Borodikin YS
Alcohol Treat Q 1992;9(1):99-105 (Journal) [ ]72 Hallucinogens.
In: Schilit R ; Gomberg ESL (eds.) DRUGS AND BEHAVIOR; A SOURCEBOOK FOR THE HELPING PROFESSIONS. Newbury Park, CA : Sage Publ., 1991, pp. 92-105. (Chapter) [Call No: RC 564 S36 1991] [ ]73 Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine. Free Link 74 Phencyclidine. Giannini AJ
In: Miller NS (ed.) COMPREHENSIVE HANDBOOK OF DRUG AND ALCOHOL ADDICTION. New York : Marcel Dekker, 1991, pp.383-94 (Chapter) [Call No: RC 564 C652 1991 (REF HAND)] [ ]75 LSD is poised for a comeback in the research lab. Gallagher W
Am Health Dec.1990:62-7 (Reprint 05179) [ ]76 Hallucinogens. Tacke U ; Ebert MH
In: Ciraulo DA ; Shader RI (eds.) CLINICAL MANUAL OF CHEMICAL DEPENDENCE. Washington DC : American Psychiatric Press, 1991, pp.259-78 (Chapter) [Call No: RC 564 C489 1991] [ ]77 Phencyclidine. Domino EF
In: Ciraulo DA ; Shader RI (eds.) CLINICAL MANUAL OF CHEMICAL DEPENDENCE. Washington DC : American Psychiatric Press, 1991, pp.279-93 (Chapter) [Call No: RC 564 C489 1991] [ ]78 Hallucinogens. Seymour RB ; Smith DE
In: Miller NS (ed.) COMPREHENSIVE HANDBOOK OF DRUG AND ALCOHOL ADDICTION. New York : Marcel Dekker, 1991, pp.455-75 (Chapter) [Call No: RC 564 C652 1991 (REF HAND)] [ ]79 Genetic differences in the n-methyl-d-aspartate receptor: effects of ethanol and phencyclidine. Hoffman PL ; Rabe CS ; Valverius P ; Grant KA ; Tabakoff B
In: Crabbe, Jr. JC ; Harris RA (eds.) THE GENETIC BASIS OF ALCOHOL AND DRUG ACTIONS. New York : Plenum Press, 1991, pp.353-68. (Chapter) [Call No: RM 301.3 G45 G46 1991] [ ]80 Feel hung over? [re: lingering effects of marijuana and LSD] Pike R
Seattle Weekly Mar.11, 1992, 5p. (Reprint 05153) [ ]81 Pyrolysis and inhalation studies with phencyclidine and cocaine. Free Link 82 Pyrolytic degradation of heroin, phencyclidine, and cocaine: identification of products and some observations on their metabolism. Free Link 83 Human hallucinogenic drug research in the United States: a present-day case history and review of the process. 84 Phenylalkylamine stimulants, hallucinogens, and designer drugs. Free Link 85 The competitive NMDA receptor antagonist, CPP, allosterically modulates NMDA receptor associated PCP binding sites in the absence of steric hinderance. Reid AA ; Bowen WD ; Setterlund C ; Rothman RB
NIDA Res Monogr 1991;105:339-40 (Chapter) [Call No: HV 5825 C617 1990] [ ]Free Link 86 Dextromethorphan inhibits but dextrorphan potentiates behavior induced by PCP and ketamine in rats. Szekely JI ; Sharpe LG ; Jaffe JH
NIDA Res Monogr 1991;105:341-4 (Chapter) [Call No: HV 5825 C617 1990] [ ]Free Link 87 Adaptive behavior in recovering female phencyclidine/polysubstance abusers. Howard J ; Beckwith L ; Rodning C
NIDA Res Monogr 1990;101:86-95 (Chapter) [Call No: RM 315 R38 1990] [ ]Free Link 88 Delta-9-THC interactions with PCP and ethanol in rats responding under a fixed consecutive number schedule. Doty P ; Picker MJ ; Dykstra LA
NIDA Res Monogr 1991;105:299 (Chapter) [Call No: HV 5825 C617 1990] [ ]Free Link 89 Importance of reactive metabolites to the in vivo hepatic clearance of phencyclidine (PCP). Free Link 90 Influence of phencyclidine (PCP) pharmacokinetics on PCP dependence after i.v. and s.c. routes of administration. Free Link 91 Does phencyclidine (PCP) use increase violent crime? Kinlock TW
J Drug Issues 1991;21(4):795-816 (Journal) [ ]92 Hallucinogens, phencyclidine, marijuana, inhalants. Weiss CJ ; Millman RB
In: Frances RJ ; Miller SI (eds.) CLINICAL TEXTBOOK OF ADDICTIVE DISORDERS. New York : Guilford Press, 1991, pp.146-70 (Chapter) [Call No: RC 564 C55 1991] [ ]93 Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects. Janiri L ; Mannelli P ; Persico AM ; Diodato S ; Tempesta E
Drug Alcohol Depend 1991;27(2):121-5 (Journal) [ PubMed abstract ]94 Lysergic acid diethylamide-induced chronic visual disturbances in an adolescent. 95 Perinatal outcome associated with PCP versus cocaine use. Tabor BL ; Smith-Wallace T ; Yonekura ML
Am J Drug Alcohol Abuse 1990;16(3-4):337-48 (Journal) [ PubMed abstract ]ADAI/UW Link 96 Phencyclidine and violent deaths in St. Louis, Missouri: a survey of medical examiners' cases from 1977 through 1986. Poklis A ; Graham M ; Maginn D ; Branch CA ; Gantner GE
Am J Drug Alcohol Abuse 1990;16(3-4):265-74 (Journal) [ PubMed abstract ]ADAI/UW Link 97 Swallowing the scroll: legal implications of the recent Supreme Court peyote cases. 98 The effects of phencyclidine on the pituitary-adrenal axis are centrally mediated in the rat. Pechnick RN ; Chun BM ; George R ; Poland RE
NIDA Res Monogr 1989;95:526-7 (Chapter) [Call No: HV 5825 C617 1989] [ ]Free Link 99 Structural and conformational aspects of the binding of aryl-alkyl amines to the phencyclidine binding site. Thurkauf A ; Monn J ; Mattson MV ; Jacobson AE ; Rice KC
NIDA Res Monogr 1989;95:51-6 (Chapter) [Call No: HV 5825 C617 1989] [ ]Free Link 100 Comparison of responses by neuropeptide systems in rat to the psychotropic drugs, methamphetamine, cocaine and PCP. Hanson GR ; Midgley LP ; Bush LG ; Johnson M ; Gibb JW
NIDA Res Monogr 1989;95:348 (Chapter) [Call No: HV 5825 C617 1989] [ ]Free Link 101 Clinical implications of PCP, NMDA and opiate receptors. Free Link 102 Behavioral pharmacology of PCP, NMDA and sigma receptors. Free Link 103 Cerebral pathways activated by PCP-like compounds: relevance to neurotransmitters and their receptors. Free Link 104 Characterization of the actions of phencyclidine on midbrain dopamine neurons. French ED ; Levenson S ; Ceci A
NIDA Res Monogr 1989;95:255-63 (Chapter) [Call No: HV 5825 C617 1989] [ ]Free Link 105 Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. Free Link 106 Disruption of schedule-controlled behavior during abstinence from phencyclidine and tetrahydrocannabinol. Free Link 107 Structural requirements for the interaction of phencyclidine with the sigma receptor. Gray NM ; Cheng BK ; Mick SJ ; Lair CM ; Contreras PC
Res Commun Subst Abuse 1990;11(1/2):49-58 (Journal) [ ]108 PCP and hallucinogens. [addiction liability] Carroll ME
Adv Alcohol Subst Abuse 1990;9(1/2):167-190 (Journal) [ ]109 The behavioral pharmacology of stimulants and hallucinogens: drug discrimination and self-administration procedures. Broadbent J ; Appel JB
In: Balfour DJK (ed.) PSYCHOTROPIC DRUGS OF ABUSE. Elmsford, NY : Pergamon Press, 1989, pp. 327-353. (Chapter) [Call No: RM 316 P79 1989] [ ]110 A syndrome identical to the neuroleptic malignant syndrome induced by LSD and alcohol [letter] Bakheit AM ; Behan PO ; Prach AT ; Rittey CD ; Scott AJ
Br J Addict 1990;85(1):150-1 (Journal) [ PubMed abstract ]UW Link 111 Phencyclidine during pregnancy: behavioral and neurochemical effects in the offspring. 112 Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships. Free Link 113 Outpatient treatment of PCP abusers. ADAI/UW Link 114 PCP: a relook at the chemistry, intoxication, psychosis and treatment. Frier RC
Psychiatr Forum 1989;14(2):52-7 (Reprint 03974) [ ]115 Clinical features and management of intoxication due to hallucinogenic drugs. Leiken JB ; Krantz AJ ; Zell-Kanter M ; Barkin RL ; Hryhorczuk DO
Med Toxicol Adverse Drug Exp 1989;4(5):324-50 (Reprint 03979) [ ]116 Phencyclidine (PCP) and phencyclidine-like compounds: a molecular graphics-molecular mechanics study. Carroll F ; Brine G ; Mascarella S
NIDA Res Monogr Ser 1988;90:122-8 (Chapter) [Call No: HV 5825 C617 1988] [ ]Free Link 117 Recognition and activation of a 5-HT receptor by hallucinogens and indole derivatives. Weinstein H ; Osman R ; Mercier G Jr
NIDA Res Monogr Ser 1988;90:243-55 (Chapter) [Call No: HV 5825 C617 1988] [ ]Free Link 118 The self-reported effects of PCP on human aggression. 119 High neonatal brain levels of phencyclidine following exposure during gestation. Pechnick RN ; Poland RE ; De Stefano E ; Cho AK
Res Commun Subst Abuse 1989;10(3):185-8 (Journal) [ ]120 Alcoholic hallucinosis: a psychiatric enigma--2. Follow-up studies. Glass IB
Br J Addict 1989;84(2):151-64 (Journal) [ ]UW Link 121 The sacred journey in dynastic Egypt: shamanistic trance in the context of the narcotic water lily and the mandrake. Emboden W
J Psychoactive Drugs 1989;21(1):61-75 (Journal) [ ]122 LSD and creativity. 123 LSD and psychotherapy. Bliss K
Contemp Drug Probl 1988;15(4):519-63 (Journal) [ ]UW Link 124 Cross sensitization between phencyclidine and methamphetamine : II. Repeated administration of methamphetamine at a high dose. Nabeshima T ; Fukaya H ; Kamei H ; Ishikawa K ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1989;10(2):95-107 (Journal) [ ]125 A private inquiry into the circumstances surrounding the 1972 death of John Gomilla, Jr., who died after allegedly consuming ten hallucinogenic mushrooms while residing in Hawaii. Allen JW
J Psychoactive Drugs 1988;20(4):451-4 (Journal) [ ]126 Some little-known hallucinogenic plants of the Aztecs. Elferink JG
J Psychoactive Drugs 1988;20(4):427-35 (Journal) [ ]127 Hallucinogenic drugs are partial agonists of the human platelet shape change response : a physiological model of the 5-HT2 receptor. 128 MMPI subtypes for chronic phencyclidine (PCP) abusers. 129 Alcoholic hallucinosis: a psychiatric enigma--1. The development of an idea. Glass IB
Br J Addict 1989;84(1):29-41 (Journal) [ ]UW Link 130 What happens to babies exposed to phencyclidine (PCP) in utero? ADAI/UW Link 131 Inpatient treatment of PCP abusers and users. ADAI/UW Link 132 Symptomatological manifestations of phencyclidine (PCP) at low serum levels. Hertzman M ; Werner M ; Kasdan P ; Pauley CJ ; Neubauer-Rossi A ; Rosenthal R ; Smith M
Subst Abuse 1988;9(4):205-15 (Journal) [ ]133 Cardiovascular and hemodynamic effects of acute and chronic phencyclidine (PCP). 134 Potentiation of phencyclidine- and serotonin agonist-induced behaviors after administration of rho-chloroamphetamine in rats. Nabeshima T ; Yamaguchi K ; Ishikawa K ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1989;10(1):37-61 (Journal) [ ]135 Cross sensitization between phencyclidine and methamphetamine. I. Repeated administration of methamphetamine at a low dose. Nabeshima T ; Fukaya H ; Kamei H ; Ishikawa K ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1989;10(1):62-76 (Journal) [ ]136 Serotonergic mechanisms of hallucinogenic drug effects. 137 Neurobiology of phencyclidine. 138 Visual function in past users of LSD : psychophysical findings. UW Link 139 Prevalence of PCP use among adolescent marijuana users. Silber TJ ; Iosefsohn M ; Hicks JM ; Getson PR ; O'Donnell R
J Pediatr 1988;112(5):827-9 (Reprint 02853) [ ]140 The relationship between phencyclidine-induced stereotyped behavior and dopamine release using in vivo voltammetry. Kameyama T ; Sugimoto A ; Yamaguchi K ; Hiramatsu M ; Furukawa H ; Nabeshima T
Res Commun Subst Abuse 1988;9(2):89-105 (Journal) [ ]141 Phencyclidine : a clinical review. Young T ; Lawson GW ; Gacono CB
In: Lawson GW ; Cooperrider CA (eds.) CLINICAL PSYCHOPHARMACOLOGY: A PRACTICAL REFERENCE FOR NONMEDICAL PSYCHOTHERAPISTS. Rockville : Aspen Publishers, 1988, pp. 187-200. (Chapter) [Call No: RM 315 C554 1988] [ ]142 Evolving ethics in psychedelic drug taking. Smith ED
J Drug Issues 1988;18(2):201-14 (Journal) [ ]143 The behavioral pharmacology of phencyclidine. Balster RL
In: Meltzer HY (ed.) PSYCHOPHARMACOLOGY: THE THIRD GENERATION OF PROGRESS. New York : Raven Press, 1987, pp. 1573-9. (Reprint 02556) [ ]144 Neurochemistry and neurophysiology of phencyclidine. Johnson KM
In: Meltzer HY (ed.) PSYCHOPHARMACOLOGY: THE THIRD GENERATION OF PROGRESS. New York : Raven Press, 1987, pp.1581-8. (Reprint 02557) [ ]145 PCP use among adolescents. Young TJ
Child Study J 1987;17(1):55-66 (Reprint 02189) [ ]146 On the stability of phencyclidine discrimination in the pigeon. McMillan DE
Alcohol Drug Res 1987;7(3):147-51 (Journal) [ ]147 PCP : an overview of the drug, its effect on youth, and management of acute intoxication. Schwartz RH
Subst Abuse 1987;8(2):10-19 (Journal) [ ]148 The abuse of hallucinogenic drugs. Johnson J
In: Herrington RE ; Jacobson GR ; Benzer DG (eds.) ALCOHOL AND DRUG ABUSE HANDBOOK. St. Louis : Warren H. Green, 1987, pp. 93-111. (Chapter) [Call No: RC 564 A44 1987] [ ]149 Clinical aspects of phencyclidine (PCP). ADAI/UW Link 150 PCP : detecting the abuser. Giannini AJ
Med Aspects Hum Sex 1987;211):100,102-4,109 (Reprint 01828) [ ]151 "More than medical significance:: LSD and American psychiatry 1953 to 1966. Neill JR
J Psychoactive Drugs 1987;19(1):39-45 (Journal) [ ]152 Effects of phencyclidine-like drugs on urine output of normally hydrated rats. Leander JD
Res Commun Subst Abuse 1987;8(1):39-42 (Journal) [ ]153 PCP abuse in New Orleans: a six-year study. Garey RE ; Daul GC ; Samuels MS ; Ragan FA ; Hite SA
Am J Drug Alcohol Abuse 1987;13(1-2):135-44 (Journal) [ ]ADAI/UW Link 154 Parental, personality, and peer correlates of psychoactive mushroom use. 155 Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. Giannini AJ ; Malone DA ; Giannini MC ; Price WA ; Loiselle RH
J Clin Pharmacol 1986;211-14 (Reprint 01744) [ ]156 Right to healthy birth : medico-legal issues in phencyclidine ingestion. 157 Isolation and identification of an endogenous ligand for the phencyclidine receptor. DiMaggio DA ; Contreras PC ; Quirion R ; O'Donohue TL
NIDA Res Monogr Ser 1986;64:24-36 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 158 Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays. Contreras PC ; Quirion R ; O'Donohue TL
NIDA Res Monogr Ser 1986;64:80-93 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 159 Anticonvulsant properties of phencyclidine and ketamine. Buterbaugh GG ; Michelson HB
NIDA Res Monogr Ser 1986;64:67-79 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 160 Involvement of dopaminergic, cholinergic, and glutamatergic mechanisms in the actions of phencyclidine-like drugs. Free Link 161 Phencyclidine (PCP) selectively blocks certain presynaptic potassium channels. Blaustein MP ; Bartschat DK ; Sorensen RG
NIDA Res Monogr Ser 1986;64:37-51 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 162 Clinical observations in the treatment of adolescent and young adult PCP abusers. Free Link 163 The long-term effects on neurodevelopment in infants exposed prenatally to PCP. Howard J ; Kropenske V ; Tyler R
NIDA Res Monogr Ser 1986;64:237-51 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 164 Legal issues associated with PCP abuse--the role of the forensic expert. Free Link 165 Diagnosis and treatment of chronic phencyclidine (PCP) abuse. Gorelick DA ; Wilkins JN ; Wong C
NIDA Res Monogr Ser 1986;64:218-28 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 166 Phencyclidine intoxication. Free Link 167 Neuropsychological assessment of phencyclidine abusers. Free Link 168 PCP and crime: just another illicit drug? Free Link 169 Phencyclidine: changing abuse patterns. Free Link 170 Clinical implications of behavioral pharmacology research on phencyclidine. Free Link 171 Further evidence of phencyclidine/sigma opioid receptor commonality. Free Link 172 Discriminative stimulus properties of PCP mimetics. Free Link 173 Psychopharmacology of phencyclidine. Free Link 174 Modulation of phencyclidine (PCP) pharmacokinetics with PCP-specific Fab fragments. Free Link 175 Phencyclidine: an update.
NIDA Res Monogr Ser 1986;64:1-260 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 176 Characterization of phencyclidine and sigma receptor-binding sites in brain. Gundlach AL ; Largent BL ; Snyder SH
NIDA Res Monogr Ser 1986;64:1-13 (Chapter) [Call No: RC 568 P43 1986] [ ]Free Link 177 Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog. 178 High and low affinity psychotomimetic opioid binding sites: characterization by a novel 3H-PCP-analog. Free Link 179 Dextrorphan: an antagonist for phencyclidine receptor. Free Link 180 An endogenous ligand from human CSE for the phencyclidine receptor. Free Link 181 An endogenous ligand for phencyclidine receptors: isolated from human brains. Free Link 182 Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands. Sircar R ; Samaan H ; Nichtenhauser R ; Snell LD ; Johnson KM ; Rivier J ; Vale W ; Zukin RS ; Zukin SR
NIDA Res Monogr Ser 1986;75:157-60 (Chapter) [Call No: RM 328 N38 P87 1986] [ ]Free Link 183 Examples of specific drug assays: marijuana/cannabinoids; cocaine; amphetamine/methamphetamine; opiates; phencyclidine; alcohol; lsd; methaquelone; barbiturates; benzodiazepines. Free Link 184 Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism. Iwamoto ET
Alcohol Drug Res 1985-86;6(4):265-76 (Journal) [ ]185 Toxicity of phencyclidine and ethanol in combination. 186 Effects of exposure to stressful stimuli on the free-choice consumption of various phenethylamines by rats. 187 Attitude and personality correlates of hallucinogenic drug use. ADAI/UW Link (under Subst Use Misuse) 188 Epidemiologic issues pertinent to international regulation of 28 stimulant-hallucinogen drugs. 189 Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO. Keup W
Drug Alcohol Depend 1986;17(2-3):169-92 (Journal) [ ]190 The stimulants and hallucinogens under consideration: a brief overview of their chemistry and pharmacology. Harris LS
Drug Alcohol Depend 1986;17(2-3):107-18 (Journal) [ ]191 Papers presented at the Committee on Problems of Drug Dependence Symposium on Stimulants and Hallucinogens. June/September, 1984.
Drug Alcohol Depend 1986;17(2-3):105-298 (Journal) [ ]192 Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. Nichols DE
J Psychoactive Drugs 1986;18(4):305-13 (Journal) [ ]193 PCP metabolites cause twitch potentiation in frog skeletal muscle. 194 The hallucinogenic basis of early Valdivia phase ceramic bowl iconography. Stahl PW
J Psychoactive Drugs 1985;17(2):105-23 (Journal) [ ]195 Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol. 196 Electrophysiological effects of cyclazocine on rat cerebellar Purkinje neurons: comparison with phencyclidine. 197 Mushroom use by college students. 198 Ketamine use in a burn center: hallucinogen or debridement facilitator? 199 On the comparative ethnopharmacology of malpighiaceous and myristicaceous hallucinogens. 200 Dream becomes nightmare: adverse reactions to LSD. 201 LSD: the varieties of psychotic experience. Cohen S
J Psychoactive Drugs 1985;17(4):291-6 (Journal) [ ]202 LSD in the supportive care of the terminally ill cancer patient. Kurland AA
J Psychoactive Drugs 1985;17(4):279-90 (Journal) [ ]203 LSD and psychotherapy. Yensen R
J Psychoactive Drugs 1985;17(4):267-77 (Journal) [ ]204 LSD hallucinations: from ergot to electric kool-aid. Siegel RK
J Psychoactive Drugs 1985;17(4):247-56 (Journal) [ ]205 Psychedelic drugs and creativity. Krippner S
J Psychoactive Drugs 1985;17(4):235-45 (Journal) [ ]206 Ethics and LSD. Clark WH
J Psychoactive Drugs 1985;17(4):229-34 (Journal) [ ]207 Re-creational uses of LSD. Stafford P
J Psychoactive Drugs 1985;17(4):219-28 (Journal) [ ]208 LSD in retrospect. 209 The effects of phencyclidine (PCP) on the compound action potential of the frog sciatic nerve. Hitner HW
Res Commun Subst Abuse 1985;6(1):37-45 (Journal) [ ]210 Simultaneous determination of phencyclidine and its major metabolites in biological samples by high-performance liquid chromatography. Nabeshima T ; Yamaguchi K ; Fukaya H ; Hiramatsu M ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1985;6(2):65-78 (Journal) [ ]211 Tissue distribution of phencyclidine following percutaneous absorption. 212 Hair analysis for detection of PCP in newly admitted psychiatric patients. 213 Selective guide to current reference sources: Opiates, phencyclidine (PCP), marijuana, and solvents. 214 Biochemistry and pharmacology of tryptamines and beta-carbolines. A minireview. 215 The hallucinogens. Cohen S
Drug Abuse Alcohol Newsl 1984;13(6):1-3 (Newsletter) [ ]216 Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion. 217 Reduction by clonidine of pressor responses induced by 4-aminopyridine and phencyclidine. 218 Phencyclidine interacts with serotonin-2 receptor, but not serotonin-1 receptor. Nabeshima T ; Noda Y ; Matsuno K ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1984;5(2):81-87 (Journal) [ ]219 Phencyclidine decreases binding capacity of serotonin-2 receptor in vitro. Nabeshima T ; Noda Y ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1984;5(3):175-186 (Journal) [ ]220 Increased startle responding in rats treated with phencyclidine. 221 The hallucinogens and the inhalants. (Symposium on clinical psychopharmacology II) Cohen S
Psychiatr Clin North Am 1984;7(4):681-8 (Reprint 00483) [ ]222 Hallucinogens. Holbrook JM
In: Bennett G ; Vourakis C ; Woolf DS (eds.) SUBSTANCE ABUSE : PHARMACOLOGIC, DEVELOPMENTAL, AND CLINICAL PERSPECTIVES. New York : Wiley, 1983, pp. 86-101. (Chapter) [Call No: RC 564 S836 1983] [ ]223 Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms. 224 Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. 225 Treatment of dependence upon stimulants and hallucinogens. Tennant FS Jr
Drug Alcohol Depend 1983;11(1):111-4 (Journal) [ ]226 The Joint French-U.S. Seminar of Phencyclidine and Related Arylcyclohexylamines. La Grande Motte (France), September 20-24, 1982. Abstracts.
Subst Alcohol Actions Misuse 1983;4(6):455-92 (Journal) [ ]227 Effect of chronic phencyclidine administration upon blood biochemical profiles in rats. 228 Evaluation of oral activated charcoal and urinary acidification in the treatment of phencyclidine intoxication in the rhesus monkey. 229 Phencyclidine (PCP) disposition kinetics in dogs: preliminary observations. 230 Dependence liability of caffeine, cocaine, nicotine, and phencyclidine. Zabik JE ; Roache JD ; Johnson W ; Nash JF ; Maickel RP
Res Commun Subst Abuse 1983;4(1):93-96 (Journal) [ ]231 Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse. Nabeshima T ; Hiramatsu M ; Amano M ; Furukawa H ; Kameyama T
Res Commun Subst Abuse 1983;4(4):273-287 (Journal) [ ]232 Phencyclidine (PCP): effects on serum testosterone and luteinizing hormone concentrations in rat. 233 Maria Sabina: wise lady of the mushrooms. 234 The pharmacology of hallucinogens. Murphree HB
In: Smart RG ; Glaser FB ; Israel Y ; Kalant H ; Popham RE ; Schmidt W (eds.) RESEARCH ADVANCES IN ALCOHOL AND DRUG PROBLEMS VOL.7. New York : Plenum Press, 1983, pp.175-205. (Chapter) [Call No: RC 565 R37 V.7] [ ]235 Modulation of phencyclidine receptor sensitivity. 236 Autoradiographic localization of the phencyclidine/sigma "opiate: receptor in rat brain. Quirion R ; Hammer RP Jr ; Herkenham M ; Pert CB
NIDA Res Monogr Ser 1982;41:178-83 (Chapter) [Call No: HV 5825 C617 1981] [ ]237 Characteristics of 68 chronic phencyclidine abusers who sought treatment. Rawson RA ; Tennant FS Jr ; McCann MA
NIDA Res Monogr Ser 1982;41:483-7 (Chapter) [Call No: HV 5825 C617 1981] [ ]238 Behavioral dependence in rhesus monkeys with chronic phencyclidine administration. Slifer BL ; Woolverton WL ; Balster RL
NIDA Res Monogr Ser 1982;41:184-9 (Chapter) [Call No: HV 5825 C617 1981] [ ]239 Oral self-administration of phencyclidine (PCP) and PCP analogs and tolerance to PCP's behavioral effects. 240 A structure activity relationship study of the cyclohexyl and aromatic rings of phencyclidine (PCP). 241 Social and political sources of drug effects: the case of bad trips on psychedelics. Bunce R
In: Zinberg NE ; Harding WM (eds.) CONTROL OVER INTOXICANT USE; PHARMACOLOGICAL, PSYCHOLOGICAL AND SOCIAL CONSIDERATIONS. New York : Human Sciences Press, 1982, pp.105-125. (Chapter) [Call No: RC 564 C67] [ ]242 Comparison of two and three compartment models of phencyclidine in man. 243 Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon. Leander JD
Subst Alcohol Actions Misuse 1982;3(4):197-203 (Journal) [ ]244 Estimation of phencyclidine in leafy mixtures and in vapor phase after smoking. 245 Tolerance to the behavioral effects of orally self-administered phencyclidine. Carroll ME
Drug Alcohol Depend 1982;9(3):213-24 (Journal) [ ]246 A study of 44 PCP-related deaths. ADAI/UW Link 247 The PCP epidemic: a critical review. Davis BL
Int J Addict 1982;17(7):1137-55 (Journal) [ ]ADAI/UW Link 248 Comparison of gastric, intestinal, and biliary secretion of phencyclidine and its metabolites in the rat. 249 Caffeine potentiation of positive inotropic and pressor effects of phencyclidine. 250 The effects of chlorpromazine on the lethality of d-amphetamine and phencyclidine in mice. 251 Pharmacodynamics of phencyclidine intoxication in the Rhesus monkey. 252 Effect of phencyclidine on gamma-aminobutyric acid receptors in the mouse. 253 Effects of phencyclidine on some characteristics of mouse neuroblastoma and melanoma cells in culture. Hu CY ; Schipper IA ; Rao NGS ; Chaturvedi AK
Res Commun Subst Abuse 1982;3(4):421-432 (Journal) [ ]254 [3H] Phencyclidine - n - oxide: quantification in biological materials and metabolism in vivo to phencyclidine. 255 Phencyclidine binding in human serum. 256 Ancient Maya mushroom connections: a transcendental interaction model. McGuire TM
J Psychoactive Drugs 1982;14(3):221-38 (Journal) [ ]257 The beta-carboline hallucinogens of South America. Schultes RE
J Psychoactive Drugs 1982;14(3):205-20 (Journal) [ ]258 Plant hallucinogens, sexuality and shamanism in the ceramic art of ancient Peru. Dobkin de Rios M
J Psychoactive Drugs 1982;14(1-2):81-90 (Journal) [ ]259 Detection of phencyclidine in hair. 260 Drug abuse of hallucinogenic plants: datura sauveolens. Hall RCW ; Popkin MK ; Stickney SK ; Gardner ER
In: Schecter AJ (ed.) DRUG DEPENDENCE AND ALCOHOLISM, VOL. 2: SOCIAL AND BEHAVIORAL ISSUES. New York : Plenum Press, 1981, pp.875-879. (Chapter) [Call No: RC 564 N37 1978 v.2] [ ]261 Hallucinogens. Ungerleider JT ; De Angelis GG
In: Lowinson JH ; Ruiz P (eds.) SUBSTANCE ABUSE: CLINICAL PROBLEMS AND PERSPECTIVES. Baltimore : Williams & Wilkins, 1981, pp.148-157. (Chapter) [Call No: RC 564 S83] [ ]262 Phencyclidine. Luisada PV
In: Lowinson JH ; Ruiz P (eds.) SUBSTANCE ABUSE: CLINICAL PROBLEMS AND PERSPECTIVES. Baltimore : Williams & Wilkins, 1981, pp.209-232. (Chapter) [Call No: RC 564 S83] [ ]263 Phencyclidine inhibition of cerebellar Purkinje neurons. Marwaha J ; Palmer M ; Hoffer B ; Freedman R
NIDA Res Monogr Ser 1981;34:187-92 (Chapter) [Call No: HV 5825 C617 1980] [ ]Free Link 264 A pharmacologic comparison between phencyclidine, its precursor, metabolites, and a quaternary derivative in the dog. Free Link 265 PCP intoxication in young children and infants. 266 Psychedelics and cocaine. Gay GR
In: Einstein S (ed.) DRUGS IN RELATION TO THE DRUG USER: CRITICAL DRUG ISSUES. New York : Pergamon Press, 1980, pp.244-273. (Chapter) [Call No: RC 564 D785 1980] [ ]267 Phencyclidine (PCP): epidemiology, pharmacology and pharmacokinetics. Stillman R ; Barnett G ; Petersen R
Adv Subst Abuse Behav Biol Res 1980;1:289-303. (Chapter) [Call No: RC 563 A38 v.1] [ ]268 [PCP] : not for human consumption. Research Triangle Institute
Hypotenuse 1980 Jul:9-11 (Reprint 00983) [ ]269 Patterns of drug use and characteristics of adolescent PCP users in drug abuse treatment. UW Link 270 Alcoholic hallucinosis and paranoia. Schuckit MA
Adv Alcoholism 1980;1(20):1-3 (Reprint 01067) [ ]271 Hallucinogenic drugs - psychopharmacology, clinical effects and management of adverse reactions. Evans BD ; Vogel WH
In: Gottheil E (ed.) ADDICTION RESEARCH AND TREATMENT : CONVERGING TRENDS. New York : Pergamon, 1979, pp.27-33. (Chapter) [Call No: RC 564 C6 1977] [ ]272 Youthful phencyclidine (PCP) users. Lerner SE ; Burns RS
In: Beschner GM ; Friedman AS (eds.) YOUTH DRUG ABUSE : PROBLEMS, ISSUES, AND TREATMENT. Lexington, MA : Lexington Books, 1979, pp. 315-52. (Chapter) [Call No: HV 5824 Y68 Y68] [ ]273 PCP : a drug of violence and death. 274 "Angel dust" : an overview of abuse patterns and prevention strategies. 275 The use of rigid analogues to probe hallucinogen receptors. Nichols DE ; Weintraub HJ ; Pfister WR ; Yim GK
NIDA Res Monogr 1978;22:70-83 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 276 The nature of opioid and LSD receptors: structural activity relationship implications. Free Link 277 Conformational studies on phenethylamine hallucinogens: the role of alpha alkyl substitution. Makriyannis A ; Knittel J
NIDA Res Monogr 1978;22:464-78 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 278 Photoelectron spectroscopic studies of hallucinogens: the use of ionization potentials in QSAR. Free Link 279 Defining the histamine H2-receptor in brain: the interaction with LSD. Green JP ; Weinstein H ; Maayani S
NIDA Res Monogr 1978;22:38-59 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 280 Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities. Free Link 281 Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships. Weinstein H ; Green JP ; Osman R ; Edwards WD
NIDA Res Monogr 1978;22:333-58 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 282 Mescaline analogs: substitutions at the 4-position. Braun U ; Braun G ; Jacob P 3d ; Nichols DE ; Shulgin AT
NIDA Res Monogr 1978;22:27-37 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 283 Progress with several models for the study of the SAR of hallucinogenic agents. Free Link 284 QSAR of agents involved in serotonin and LSD binding sites. Chan YL ; Lien EJ ; Shih JC
NIDA Res Monogr 1978;22:103-13 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 285 Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.
NIDA Res Monogr 1978;22:1-5 (Chapter) [Call No: RM 301.42 Q28 1978] [ ]Free Link 286 LSD and other hallucinogens. Pradhan SN
In: Pradhan S ; Dutta S (eds.) DRUG ABUSE: CLINICAL AND BASIC ASPECTS. St. Louis : CV Mosby, 1977, pp.174-198. (Chapter) [Call No: RC 566 D74] [ ]287 Abuse of LSD and other hallucinogenic drugs. Pradhan SN ; Hollister LE
In: Pradhan S ; Dutta S (eds.) DRUG ABUSE: CLINICAL AND BASIC ASPECTS. St. Louis : CV Mosby, 1977, pp.274-289. (Chapter) [Call No: RC 566 D74] [ ]288 Phencyclidine (PCP) : a local and national perspective. Graeven DB
Addict Diseases 1977;3(2):243-51 (Journal) [ ]289 Observations of alcoholics in the peyote ritual: a pilot study. Pascarosa P ; Futterman S ; Halsweig M
In: Seixas FA ; Eggleston S (eds.) WORK IN PROGRESS ON ALCOHOLISM. (Ann NY Acad Sci v.273) New York : New York Academy of Sciences, 1976, pp.518-524. (Chapter) [Call No: Q 11 N5 v.273] [ ]290 Drinking as a precursor to hallucinogenic drug usage. Bogg RA
Drug Forum 1975-1976;5(1):55-67 (Reprint 03593) [ ]291 The epidemiology of psychoactive and hallucinogenic drug use. Mercer GW ; Smart RG
In: Gibbins RJ ; Israel Y ; Kalant H ; Popham RE ; Schmidt W ; Smart RG (eds.) RESEARCH ADVANCES IN ALCOHOL AND DRUG PROBLEMS, VOL. 1. New York : Wiley & Sons, 1974, pp.303-354. (Chapter) [Call No: RC 565 R37 v.1] [ ]292 Peyote in the treatment of alcoholism among American Indians. 293 The relationship of social and personality characteristics to hallucinogen use among college females. 294 Lysergic acid diethylamide : its effects on human chromosomes and the human organism in utero : a review of current findings. Titus RJ
Int J Addict 1972;7(4):701-14 (Reprint 01133) [ ]ADAI/UW Link 295 The hallucinogenic (LSD) experience. Gregory RJ
J Drug Educ 1972;2(2):171-178 (Journal) [ ]296 The psychedelic experience: High adolescence. Chunko JA
J Drug Educ 1972;2(3):241-248 (Journal) [ ]